Animal Pharm is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Virtual venture brings adjuvants into the 21st century

In April 2013, VaxLiant was created in the US as a joint venture between biologics development firm Benchmark Biolabs and animal health products distributor AgriLabs. The venture is aiming to market its ready-to-use, custom vaccine adjuvants, with an eye on avian flu and other markets. Four months after its creation, Animal Pharm senior reporter Joseph Harvey met with both sides of the business in downtown Kansas City.



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts